Generating iPSCs: translating cell reprogramming science into scalable and robust biomanufacturing strategies.
Induced pluripotent stem cells (iPSCs) have the potential to transform drug discovery and healthcare in the 21(st) century. However, successful commercialization will require standardized manufacturing platforms. Here we highlight the need to define standardized practices for iPSC generation and pro...
Main Authors: | Silva, M, Daheron, L, Hurley, H, Bure, K, Barker, R, Carr, A, Williams, D, Kim, H, French, A, Coffey, P, Cooper-White, J, Reeve, B, Rao, M, Snyder, E, Ng, K, Mead, B, Smith, J, Karp, J, Brindley, D, Wall, I |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Cell Press
2015
|
Similar Items
-
Nanog-Independent Reprogramming to iPSCs with Canonical Factors
by: Ava C. Carter, et al.
Published: (2014-02-01) -
The Defects of Epigenetic Reprogramming in Dox-Dependent Porcine-iPSCs
by: Aiwen Jiang, et al.
Published: (2022-10-01) -
The Developmental Potential of iPSCs Is Greatly Influenced by Reprogramming Factor Selection
by: Buganim, Yosef, et al.
Published: (2017) -
Reprogramming LCLs to iPSCs Results in Recovery of Donor-Specific Gene Expression Signature.
by: Samantha M Thomas, et al.
Published: (2015-05-01) -
Bioprocess decision support tool for scalable manufacture of extracellular vesicles
by: Ng, K, et al.
Published: (2018)